creatine has been researched along with Aplasia Pure Red Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Y | 1 |
| Chen, M | 1 |
| Yang, C | 1 |
| Ruan, J | 1 |
| Wang, S | 1 |
| Han, B | 1 |
1 other study available for creatine and Aplasia Pure Red Cell
| Article | Year |
|---|---|
Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.
Topics: Creatine; Cyclosporine; Humans; Immunosuppressive Agents; Prospective Studies; Red-Cell Aplasia, Pur | 2022 |